Zobrazeno 1 - 4
of 4
pro vyhledávání: '"A Llona Armada"'
Autor:
A Aguirrezabal Arredondo, A Llona Armada, JA Dominguez Menendez, I Martinez Aguirre, M Alonso Diez, M. Álvarez Lavín, U Blazquez Urtizberea
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background The neuropathic pain management which is refractory to opioids treatments demands the development of new analgesics or new ways of using our classic medicines. Ketamine is scarcely used as an anaesthetic, but with an increase in indication
Autor:
A Llona Armada, MJ Yurrebaso Ibarretxe, MM Alvarez Lavin, I. Loizaga Díaz, S Vallinas, Z Perez España
Publikováno v:
European Journal of Hospital Pharmacy. 21:A58.1-A58
Background Adherence to injectable disease-modifying drugs becomes an imperative to achieve a reduction in the number of relapses and delay disease symptoms in relapsing-remitting multiple sclerosis patients. From our service, we estimate patient adh
Autor:
I Loizaga-Diaz, Z Perez-Espana, AV Aguirrezabal-Arredondo, FJ Goikolea-Ugarte, S Vallinas-Hidalgo, MJ Yurrebaso-Ibarreche, A Llona-Armada
Publikováno v:
European Journal of Hospital Pharmacy. 20:A147.3-A148
Background Biological agents have changed the treatment of psoriasis, and are used for long-term treatment. For this reason adherence to the treatment is a marker of success. Purpose To quantify the adherence of patients with psoriasis to treatment w
Autor:
MJ Yurrebaso Ibarreche, B. Balzola Regout, FJ Goikolea Ugarte, J. A. Domínguez Menéndez, LM Mendarte Barrenechea, A Llona Armada
Publikováno v:
European Journal of Hospital Pharmacy. 20:A56.1-A56
Background Electronic health records systems facilitate reconciliation of patients’ medicines. However, chronic medicines prescribed by hospital physicians and dispensed only at hospitals such as HIV treatments, are not yet recorded in primary care